A compound with the SMILES CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(NC(=O)c4ccc5n[nH]nc5c4)c3)cc2C(F)(F)F)CC1 has a human ether-à-go-go related gene (hERG) inhibition at 1uM of 11.409\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(NC(=O)c4ccc5n[nH]nc5c4)c3)cc2C(F)(F)F)CC1
CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(NC(=O)c4ccc5n[nH]nc5c4)c3)cc2C(F)(F)F)CC1
N-[5-[[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]carbamoyl]-2-methylphenyl]-2H-benzotriazole-5-carboxamide